FOXP3 and systemic lupus erythematosus: However, these studies have demonstrated quite contradictory results: some reported a reduced frequency and/or impaired regulatory function of circulating Foxp3+ Treg cells [19–21] in SLE patients in comparison to healthy controls, but others found an increased or comparable frequency of circulating Foxp3+ Treg cells [22, 23].